GlobalSkin is pleased to report that despite the pandemic’s challenges our mighty GRIDD team, including our staff and researchers from Cardiff and Hamburg Universities, succeeded in completing our Phase 2 patient interviews! These interviews were included in Phase 2 to fill patient data gaps identified after the initial round of research was undertaken in June 2019. Over the past two months, researchers conducted a total of 28 interviews with patients from nine countries focusing on five identified conditions: acne; psoriasis; eczema; vitiligo; and scarring alopecia. Learn more about GRIDD and next steps in the project by reading the full article. |